The system patent is for cassettes, processing the cells and those systems were built for small deployments in labs, not commercial production. It has always been my point that deploying those old systems at best would be a quick and dirty 1.0, and the company would need full control of their manufacturing to incrementally improve efficiency, as one does in a manufacturing process. Ford when it made the Model T did not stand still to today in how it made cars. You add in more and more automation, simultaneous processing. If cartridges need to sit for x days for one part of the process and another x days for another, why should it tie up the entire process?
Commercial deployments are typically different and they said so. We just don’t have all the details as to how. But the core process is that all of the processing of the cells happens in a sealed “cartridge” with different chambers that handle different parts of the process.
News 
Market Data 
Discover 
AI
